Clincosm LogoSign in Get a demo

Hemoglobinopathies

Showing 26 - 42 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pediatric Cancer, Immune System Disorder, COVID-19 Trial in United States

Unknown status
  • Pediatric Cancer
  • +3 more
    • Hartford, Connecticut
    • +16 more
    Jun 22, 2020

    Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia Trial in New York (CD34 Stem Cell Selection

    Active, not recruiting
    • Bone Marrow Failure Syndrome
    • +15 more
    • CD34 Stem Cell Selection Therapy
    • New York, New York
      Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
    Jun 17, 2020

    Anemia, Anemia, Iron-Deficiency, Hemoglobinopathies Trial in Rovieng (Lucky Iron Fish - home fortification system, 18 mg

    Completed
    • Anemia
    • +2 more
    • Lucky Iron Fish - home fortification system
    • +2 more
    • Rovieng, Preah Vihear, Cambodia
      Rovieng Health Centre
    Mar 14, 2018

    Humans With Informative Iron or Erythroid Phenotypes

    Terminated
    • Hemoglobinopathies
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Feb 13, 2018

      Iron Overload Detected by Pancreas T2* MRI in High-Risk

      Withdrawn
      • Iron Overload
      • +3 more
      • Continuous Glucose Monitoring (CGM)
      • +2 more
      • (no location specified)
      Jul 24, 2017

      Hepatitis C Virus Infection in Patients With Hemoglobinopathies

      Completed
      • Hepatitis C, Chronic
      • Hemoglobinopathies
      • Antiviral drugs
      • (no location specified)
      May 9, 2017

      Hemoglobinopathies, MDS, Other Inherited or Acquired Anaemia Trial in Australia (deferasirox)

      Completed
      • Hemoglobinopathies
      • +6 more
      • Adelaide, Australia
      • +3 more
      Feb 20, 2017

      Anemia, Sickle Cell, Hematologic Diseases, Hemoglobinopathies Trial (hydroxyurea)

      Completed
      • Anemia, Sickle Cell
      • +2 more
      • (no location specified)
      Sep 15, 2016

      Sickle Cell Disease, Thalassemia, Hemoglobinopathies Trial in Pittsburgh (Busulfan; Fludarabine; cyclosporine A and MMF)

      Completed
      Has Results
      • Sickle Cell Disease
      • +2 more
      • Busulfan; Fludarabine; cyclosporine A and MMF
      • Pittsburgh, Pennsylvania
        Children's Hospital of Pittsburgh
      Jul 8, 2016

      Anemia, Sickle Cell, Hematologic Diseases, Hemoglobinopathies Trial (hydroxyurea)

      Completed
      • Anemia, Sickle Cell
      • +2 more
      • (no location specified)
      Apr 13, 2016

      Anemia, Sickle Cell, Hematologic Diseases, Hemoglobinopathies Trial (penicillin)

      Completed
      • Anemia, Sickle Cell
      • +4 more
      • (no location specified)
      Mar 24, 2016

      Anemia, Sickle Cell, Cerebral Embolism and Thrombosis, Cerebrovascular Disorders Trial (blood transfusion)

      Completed
      • Anemia, Sickle Cell
      • +4 more
      • blood transfusion
      • (no location specified)
      Dec 21, 2015

      Non Malignant Disorders, Immunodeficiencies, Congenital Marrow Failures Trial in Durham (Unrelated Umbilical Cord Blood

      Completed
      Has Results
      • Non Malignant Disorders
      • +7 more
      • Unrelated Umbilical Cord Blood Transplant
      • Reduced Intensity Conditioning
      • Durham, North Carolina
        Duke University Medical Center Pediatric Blood and Marrow Transp
      Jul 23, 2014

      Anemia (Iron-Loading), Beta-Thalassemia, Hematologic Diseases Trial (chelation therapy)

      Completed
      • Anemia (Iron-Loading)
      • +5 more
      • chelation therapy
      • (no location specified)
      Feb 10, 2014

      Hemoglobinopathies, Sickle Cell Disease, Thalassemia Trial in United States (Busulfex, Fludarabine, Alemtuzumab)

      Completed
      Has Results
      • Hemoglobinopathies
      • +2 more
      • Atlanta, Georgia
      • +5 more
      Jul 24, 2013

      Hemoglobinopathies, Anemia, Sickle Cell, Hemoglobin SC Disease Trial in Boston (Busulfan, Fludarabine, FK506)

      Terminated
      • Hemoglobinopathies
      • +4 more
      • Boston, Massachusetts
        Dana-Farber Cancer Institute/Harvard Cancer Center, Brigham and
      Apr 30, 2013

      Hemoglobinopathies Trial in Palermo (PEG-IFN alpha2a or PEG-IFN alpha2b and Ribavirin)

      Unknown status
      • Hemoglobinopathies
      • PEG-IFN alpha2a or PEG-IFN alpha2b and Ribavirin
      • Palermo, Italy
        AOVCervello
      Apr 22, 2009